Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 2,276 | 2,459 | N/A | N/A |
| TOTAL | $2,375 | $2,583 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 20 | 20 | N/A | N/A |
| Other Non-Current Assets | 24 | 8 | 0 | 0 |
| TOTAL | $44 | $28 | $N/A | $N/A |
| Total Assets | $2,419 | $2,611 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 677 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,273 | 667 | 0 | 0 |
| Other current liabilities | 97 | N/A | N/A | N/A |
| TOTAL | $2,047 | $667 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 1,764 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 23 | 538 | 0 | 0 |
| TOTAL | $1,787 | $538 | $N/A | $N/A |
| Total Liabilities | $3,834 | $1,205 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 2 | 2 | N/A | N/A |
| Retained earnings | -27,371 | -19,663 | N/A | N/A |
| Other shareholders' equity | 23,929 | 19,069 | 0 | 0 |
| TOTAL | $-1,415 | $1,406 | $N/A | $N/A |
| Total Liabilities And Equity | $2,419 | $2,611 | $0 | $0 |